Department of Endocrinology/Medicine, Hospital Sant Pau, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER 747), Institut d'Investigació Biomèdica-Sant Pau (IIB-SANT PAU), Barcelona, Spain.
Universitat Autònoma de Barcelona, Barcelona, Spain.
Drugs. 2017 May;77(8):829-842. doi: 10.1007/s40265-017-0735-z.
Cushing's syndrome (CS) results from chronic exposure to cortisol excess, produced by the adrenal cortex. Hypercortisolism predisposes to psychiatric and neurocognitive disorders, mainly to depression and anxiety disorders. Screening tools to identify psychiatric symptoms are available for clinicians in their daily practice, although a specific diagnosis should be performed by specialists. Even if psychiatric symptoms improve after remission of hypercortisolism, complete recovery may not be achieved. Given the burden of these symptoms, psychiatric or psychological monitoring and treatment should be offered through all phases of CS, with a multidisciplinary approach. The aim of this article is to review data on the prevalence, diagnosis and management of psychiatric symptoms seen in patients with CS and to propose therapeutic approaches that may be followed in clinical practice. The prevalence of different psychiatric disorders has been described in both the active phase and after CS remission. Patients may not talk spontaneously about psychiatric symptoms they present, thus clinicians should ask directly about them. We recommend the use of screening tools in clinical practice to detect and treat these symptoms promptly. Even if reference endocrinologists cannot perform a definite psychiatric diagnosis, it will be important to ask patients directly about the presence of symptoms and refer if necessary to a psychiatrist. Additionally, patient information and educational programmes could be useful to manage psychiatric symptoms and to improve quality of life in patients with CS.
库欣综合征(CS)是由于肾上腺皮质长期暴露于过量皮质醇引起的。皮质醇过多会导致精神和神经认知障碍,主要表现为抑郁和焦虑障碍。目前已经有一些筛查工具可用于临床医生在日常实践中识别精神症状,但应由专家进行明确诊断。即使在皮质醇过多症缓解后精神症状得到改善,也可能无法完全恢复。鉴于这些症状的负担,应在 CS 的所有阶段通过多学科方法提供精神或心理监测和治疗。本文的目的是回顾 CS 患者中精神症状的患病率、诊断和管理数据,并提出可能在临床实践中遵循的治疗方法。在 CS 活动期和缓解后,不同精神障碍的患病率均有描述。患者可能不会主动提及他们所出现的精神症状,因此临床医生应直接询问。我们建议在临床实践中使用筛查工具来及时发现和治疗这些症状。即使参考内分泌科医生无法进行明确的精神诊断,直接询问患者症状的存在并在必要时转介给精神科医生也很重要。此外,患者信息和教育计划可能有助于管理 CS 患者的精神症状并提高生活质量。